Trial intelligence / Profile preview

Local Physiological Effects Following Injection of Levcromacalim

NCT03726242Completed

Sponsor
Dansk Hovedpinecenter
Start
Nov 2018
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Trial of levcromakalim in pain (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoints: Occurrence and change of pain from baseline and Occurrence and change of Itching from baseline. Started Nov 2018; status: completed.

02

Drugs

levcromakalim
03

Conditions

pain

Beyond the preview

Go deeper on NCT03726242.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03726242.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call